1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal

Julia B Cordero1, Mario Cozzolino, Yan Lu

  • 1Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Insights

1,25(OH)(2)D(3) (calcitriol) inhibits cancer cell growth by disrupting the TGF-alpha/EGFR signaling pathway. This vitamin D3 metabolite alters epidermal growth factor receptor (EGFR) localization and reduces downstream signaling, impacting cell proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • The antiproliferative effects of 1,25(OH)(2)D(3) (calcitriol) are established but not fully understood at the molecular level.
  • Tumor and hyperplastic tissue growth driven by co-expressed epidermal growth factor receptor (EGFR) and transforming growth factor-alpha (TGF-alpha) are sensitive to 1,25(OH)(2)D(3).

Purpose of the Study:

  • To investigate the hypothesis that 1,25(OH)(2)D(3) modulates the TGF-alpha/EGFR autocrine growth loop.
  • To elucidate the molecular mechanisms by which 1,25(OH)(2)D(3) regulates EGFR-mediated growth signals.

Main Methods:

  • Utilized human epidermoid A431 cells, characterized by EGFR and TGF-alpha overexpression driving autocrine signaling.
  • Assessed the effects of 1,25(OH)(2)D(3) on A431 cell proliferation, EGFR and TGF-alpha cellular localization, EGFR and ERK1/2 phosphorylation, and EGFR nuclear translocation.

Main Results:

  • 1,25(OH)(2)D(3) significantly inhibited both autocrine and epidermal growth factor (EGF)-induced A431 cell proliferation.
  • Observed alterations in the cellular distribution of TGF-alpha and EGFR, alongside inhibition of ligand-dependent EGFR and ERK1/2 phosphorylation.
  • Demonstrated impaired nuclear translocation of activated EGFR, reduced binding to AT-rich DNA sequences, and decreased cyclin D1 promoter transcriptional activity.

Conclusions:

  • 1,25(OH)(2)D(3) effectively down-regulates EGFR growth signaling by altering EGFR membrane trafficking.
  • The findings reveal a novel mechanism for the antiproliferative action of 1,25(OH)(2)D(3) involving the disruption of the EGFR signaling pathway.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...